Purposing Saikosaponins for the treatment of COVID-19

被引:26
作者
Bahbah, Eshak I. [1 ]
Negida, Ahmed [2 ,3 ,4 ]
Nabet, Mohamed Salah [5 ]
机构
[1] Al Azhar Univ, Sch Med, Dumyat, Egypt
[2] Univ Portsmouth, Sch Pharm & Biol Sci, Portsmouth, Hants, England
[3] Zagazig Univ, Sch Med, Sharkia, Egypt
[4] Zagazig Univ, Zagazig Univ Hosp, Sharkia 44523, Egypt
[5] Zagazig Univ, Sch Pharm, Dept Pharmaceut & Ind Pharm, Sharkia, Egypt
关键词
D O I
10.1016/j.mehy.2020.109782
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页数:1
相关论文
共 4 条
[1]   Antiviral effects of saikosaponins on human coronavirus 229E in vitro [J].
Cheng, Pei-Win ;
Ng, Lean-Teik ;
Chiang, Lien-Chai ;
Lin, Chun-Ching .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2006, 33 (07) :612-616
[2]  
Yan Y.-M., 2020, Preprints, DOI [10.20944/preprints202002.0254.v1, DOI 10.20944/PREPRINTS202002.0254.V2]
[3]   Antiviral and immunoregulatory role against PCV2 in vivo of Chinese herbal medicinal ingredients [J].
Yang, Haifeng ;
Chen, Xiaolan ;
Jiang, Chunmao ;
He, Kongwang ;
Hu, Yiyi .
JOURNAL OF VETERINARY RESEARCH, 2017, 61 (04) :405-410
[4]   A systematic review of the active saikosaponins and extracts isolated from Radix Bupleuri and their applications [J].
Yuan, Bochuan ;
Yang, Rui ;
Ma, Yongsheng ;
Zhou, Shan ;
Zhang, Xiaodong ;
Liu, Ying .
PHARMACEUTICAL BIOLOGY, 2017, 55 (01) :620-635